Calcium Entry Blockers in Cardiovascular and Cerebral Dysfunctions: Developments in Cardiovascular Medicine, cartea 40
Editat de T. Godfraind, A.G. Herman, D. Wellensen Limba Engleză Paperback – 4 noi 2011
Din seria Developments in Cardiovascular Medicine
- 5% Preț: 1484.50 lei
- 5% Preț: 375.17 lei
- 5% Preț: 354.10 lei
- 5% Preț: 1342.97 lei
- 5% Preț: 356.69 lei
- 5% Preț: 1040.19 lei
- 5% Preț: 1362.24 lei
- 5% Preț: 357.02 lei
- 5% Preț: 349.04 lei
- 5% Preț: 360.31 lei
- 5% Preț: 2005.33 lei
- 5% Preț: 348.02 lei
- 5% Preț: 347.33 lei
- 5% Preț: 351.65 lei
- 5% Preț: 351.49 lei
- 5% Preț: 741.85 lei
- 5% Preț: 675.55 lei
- 5% Preț: 1040.19 lei
- 5% Preț: 355.81 lei
- 5% Preț: 353.89 lei
- 5% Preț: 685.26 lei
- 5% Preț: 1045.00 lei
- 5% Preț: 2005.00 lei
- 5% Preț: 678.30 lei
- 5% Preț: 352.53 lei
- 5% Preț: 684.21 lei
- 5% Preț: 625.29 lei
- 5% Preț: 355.66 lei
- 5% Preț: 1347.90 lei
- 5% Preț: 677.61 lei
- 5% Preț: 748.44 lei
- 5% Preț: 682.66 lei
- 5% Preț: 3016.52 lei
- 5% Preț: 1343.19 lei
- 5% Preț: 743.22 lei
- 5% Preț: 676.94 lei
- 5% Preț: 351.30 lei
- 5% Preț: 356.24 lei
- 5% Preț: 626.00 lei
- 5% Preț: 348.81 lei
Preț: 356.67 lei
Preț vechi: 375.45 lei
-5% Nou
Puncte Express: 535
Preț estimativ în valută:
68.28€ • 74.14$ • 57.42£
68.28€ • 74.14$ • 57.42£
Carte tipărită la comandă
Livrare economică 13-19 decembrie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9789400960350
ISBN-10: 9400960352
Pagini: 336
Ilustrații: 325 p.
Dimensiuni: 156 x 244 x 18 mm
Ediția:Softcover reprint of the original 1st ed. 1984
Editura: SPRINGER NETHERLANDS
Colecția Springer
Seria Developments in Cardiovascular Medicine
Locul publicării:Dordrecht, Netherlands
ISBN-10: 9400960352
Pagini: 336
Ilustrații: 325 p.
Dimensiuni: 156 x 244 x 18 mm
Ediția:Softcover reprint of the original 1st ed. 1984
Editura: SPRINGER NETHERLANDS
Colecția Springer
Seria Developments in Cardiovascular Medicine
Locul publicării:Dordrecht, Netherlands
Public țintă
ResearchCuprins
I: Introductory considerations.- The major steps in the discovery of calcium entry blockers..- Basic mechanisms and classification of calcium entry blockers..- Calcium entry blockers: perspectives..- Twenty-seven calcium entry blockers in development: a new chapter in pharmacology..- II: Calcium entry blockers and peripheral circulatory function..- Calcium-ions and excitation contraction coupling in vascular smooth muscle cells..- Laser microprobe mass analysis (LAMMA) as a technique to quantitate Ca2+ ions..- Vascular pharmacology of calcium entry blockers..- Calcium homeostasis in human red blood cells..- Impact of Ca2+ entry blockers on Ca2+ dependent mechanisms in red blood cells, platelets and endothelial cells..- Red blood cell microrheology and calcium antagonists..- Calcium e ntry blockers in the treatment of peripheral obliterative arterial disease..- III: Calcium entry blockers and myocardial function..- Pharmacology of calcium entry blockers in animal and human coronary arteries..- Calcium paradox and calcium entry blockers..- Myocardial oxygen deprivation and calcium deprivation: ultrastructural characteristics and clinical significance..- Basic and clinical aspects of myocardial protection by calcium entry blockers..- Effect of calcium entry blockers on impaired left ventricular wall motion..- The influence of Ca2+ entry blockers on hemodynamics and coronary blood flow, and its importance for the treatment of angina pectoris..- The use of selective calcium antagonism in variant (vasospastic) and classical (effort) angina pectoris..- Calcium entry blockers in cardiovascular therapy. Influence of diltiazem on hemodynamics and coronary blood flow..- IV: Calcium entry blockers and cerebral function..- Calcium entry blockers and cerebral function: an introduction..- Calcium entry blockers and cerebral resuscitation..- Effect of calcium entry blockers in models of brain hypoxia..- Calcium entry blockers in the therapy of vertebrobasilar insufficiency..- Calcium entry blockers and pharmacological aspects of migraine..- Clinical evaluation of calcium entry blockers in migraine..- V: Calcium entry blockers in hypertension treatment..- Double-blind comparison of the antihypertensive effects of verapamil and nifedipine..- Treatment of hypertension emergencies and chronic arterial hypertension with calcium entry blockers..- The effect of nifedipine on arterial pressure and reflex cardiac control..- Concluding remarks.- Why are Ca2+ entry blockers effective in the treatment of hypertension and tissue hypoxia?.- List of authors and co-authors.